SCHEMBL4249306

SCHEMBL4249306

Cc1ccc(OC(=O)c2ccccc2N)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.66
HSD17B10 Q99714 6/20 0.66
HPGD P15428 5/20 0.66
KDM4E B2RXH2 2/20 0.66
GLA P06280 1/20 0.66
PTK2B Q14289 1/20 0.60
RXFP1 Q9HBX9 1/20 0.60
CFTR P13569 1/20 0.58
TP53 P04637 1/20 0.54
MAPK1 P28482 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MAPT P10636 4/20 0.51
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
NPSR1 Q6W5P4 2/20 0.51
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9861291 0.91 HSD17B10 (0.71) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL208281 0.87 PTK2B (0.70) ALDH1A1HSD17B10HPGDKDM4EPTK2B
SCHEMBL4246573 0.86 ALDH1A1 (0.66) ALDH1A1HSD17B10HPGDKDM4EGLA
Methyl Alcohol SCHEMBL28862398 0.86 HSD17B10 (0.65) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL6430896 0.86 ALDH1A1 (0.65) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL444509 0.85 HSD17B10 (0.64) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL10983921 0.84 PTK2B (0.66) ALDH1A1HSD17B10HPGDKDM4EPTK2B
SCHEMBL25063269 0.83 HSD17B10 (0.61) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL25063288 0.83 HSD17B10 (0.61) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL4249090 0.83 HSD17B10 (0.61) ALDH1A1HSD17B10HPGDKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131527-A1 NOVEL ANTHRANILIC ACID DERIVATIVES AND CHLORIDE CHANNEL BLOCKING AGENT CONTAINING THE SAME CLIC1, ASIC1, CLIC4 ALDH1A1 1179/4885HSD17B10 1998/4885HPGD 2548/4885
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885HSD17B10 2241/4885HPGD 3064/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 ALDH1A1 1427/4885HSD17B10 2241/4885HPGD 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.